The VA Office of Research and Development and the University of Colorado, Denver are hosting a clinical trial compares the effectiveness of physical therapy after a total hip arthroplasty. The study is being performed in response to an estimate that total hip arthroplasties are expected to double over the next twenty years and a decrease in physical activities and life quality from standard physical therapy. Two physical therapy programs will be monitored: a standard of care physical therapy and a physical therapy program targeting core and hip muscle strength and function.
This is an interventional study with an experimental arm with an intervention of functional strength integration and a control group arm of usual care. The outcomes will be measured using tests, surveys, indexes, and scales including:
- 6 minute walk test
- 4 meter walk test
- 30 second sit-to-stand test
- Functional Gait Assessment
- Isometric strength
- Modified Trendelenburg test
- Peak internal hip abduction moment
- Veterans RAND 12-item health survey
- Western Ontario and McMaster Universities Osteoarthritis Index
- Patient Activation Measure (PAM)
- Motivation scale
- Falls, injury, pain
- BMI less than or equal to 40
- Receiving unilateral primary total hip arthroplasty for osteoarthritis
- Severe contralateral leg OA (greater than or equal to a 5/10 pain level while climbing stairs)
- Unstable orthopaedic conditions
- Neurological or pulmonary problems that severely limit function
- Uncontrolled hypertension or diabetes
- Use of illegal substances
You may participate in this study at Rocky Mountain Regional VA Medical Center, Aurora, CO in Aurora, Colorado, United States, 80045. IF you have any questions or concerns, please contact Jennifer E Stevens-Lapsley, PhD at 303-949-9304 or at Jennifer.Stevens-Lapsley@va.gov.
This study is sponsored by the VA Office of Research and Development and is collaborated by the University of Colorado, Denver. Jennifer E Stevens-Lapsley, PhD of Rocky Mountain Regional VA Medical Center, Aurora, CO serves as the Principal Investigator.